Pathology of Bone and Soft Tissue-Lecture
Pathology of Bone and Soft Tissue-Lecture
Soft tissue
Dr. Nirmalya Chakrabarti
MD (Pathology), Gold Medalist [WBUHS]
Deptt. Of Pathology, Malda Medical college, Malda
Competencies:
Core Competencies:
PA-33.1: Classify and describe the etiology, pathogenesis, manifestations, radiologic and
morphologic features and complications of osteomyelitis.
PA-33.2: Classify and describe the etiology, pathogenesis, manifestations, radiologic and
morphologic features and complications and metastases of bone tumors. (Bone Tumors:
GCT, Osteosarcoma, Ewing’s Sarcoma).
PA-33.3: Classify and describe the etiology, pathogenesis, manifestations, radiologic and
morphologic features and complications and metastases of soft tissue tumors.
Non core Competencies: PA-33.4: Paget disease of Bone, PA-33.5: Rheumatoid Arthritis.
Microanatomy of Bone
1. Osteoblasts: uninucleate cells along new bone-forming surfaces,
synthesize bone matrix, alkaline phosphatase is its marker.
2. Osteocytes: those osteoblasts incorporated in bone matrix during its
synthesis, found in lacunae of bone matrix.
3. Osteoclasts: large multinucleate cells of mononuclear-macrophage origin,
found along endosteal surface, cause bone resorption activity determind
by acid phosphatase
4. Osteoid matrix: type 1 collagen, hydroxyproline and hydroxylysine.
Bone remodeling = interactive balance between osteoblastic formation and
osteoclastic resorption [ under influence of Vit. D1, Parathyroid hormone
and calcitonin in calcium metabolism].
Osteomyelitis: inflammation of bone and marrow,
virtually always secondary to infection.
Pyogenic osteomyelitis (caused by pyogenic organisms) – clinically 2
types: acute and chronic, histologically 3 types: acute, sub-acute and
chronic.
Tuberculous osteomyelitis (caused by M. tuberculosis in low income
countries where there are cases of pulmonary and extrapulmonary
tuberculosis).
Salmonella osteomyelitis (caused by Salmonella typhi after attack of
typhoid fever among children with sickle cell anemia).
Pyogenic osteomyelitis
Patient Profile:
Developing countries – hematogenous spread of infection, long bones of
infants and young children (5-15 yrs), after trivial mucosal injuries or from
minor skin infections.
Developed countries – direct extension from a contiguous site, jaw and
skull involvement.
Patient of all ages – compound fractures, surgical procedures, infection of
limbs in diabetics.
Most dangerous among infants: can spread to a joint resulting septic
arthritis followed by cartilage destruction and permanent disability.
Pyogenic osteomyelitis
Etiologic organisms:
Most commonly Staphylococcus aureus.
Less frequently
• Mixed bacterial infections (direct spread/ inoculation during surgery/ open #).
Pathogenesis:
Pyogenic organisms reach bone via blood circulation
Bacteria get lodged in metaphysis due to stasis of blood resulting from hair-pin
arrangement of blood vessels.
Host bone initiates inflammatory responses leading to bone destruction & pus
formation.
Pus in medullary cavity spreads in:
1. Along medullary cavity: thrombosis of medullary vessels, loss of blood supply.
2. Out of cortex: i. pus travels via Volkmann’s canal to subperiosteal location, periosteum
is lifted, damage of periosteal vessels, loss of blood supply, segment of avascular
necrosed bone (sequestrum).
ii. Subperiosteal pus generates subperiosteal reactive new bone
formation (periosteal reaction), encases necrosed bone – known as involucrum (with
holes – cloacae for drainage of pus)
iii. Perforation of periosteum- pus comes out to muscular/ subcutaneous
plane the to skin forming discharging sinus.
3. Other directions: to joints (hip/shoulder) causing acute septic arthritis.
Gross Morphology:
Contd..
Sequestrum:
Sequestrum is a piece of dead bone, surrounded by infected granulation tissue
trying to ‘eat’ the sequestrum away.
It appears pale and has a smooth inner and rough outer surface because the latter
is being constantly eroded by the surrounding granulation tissue
Involucrum:
Involucrum is the dense sclerotic bone overlying a sequestrum.
There may be some holes in the involucrum for pus to drain out. These holes are
called cloacae.
The bony cavities are lined by infected granulation tissue.
Histological features:
Acute osteomyelitis: features of acute inflammation, edema & bone necrosis.
All osteosarcoma pts are assumed to have occult metastasis at the time of
diagnosis.
Route of metastasis: via hematogenous route to lungs, bones, brain & other sites.
5 year survival rate for those pts without overt mets – 70%
5 year survival rate for those with clinically evident mets/recurrent ds/secondary
osteosarcoma - <20%
Treatment options: Neoadjuvant chemotherapy, surgery & post-operative
adjuvant chemotherapy.
Giant cell tumor (Osteoclastoma):
Common bone tumor with variable growth potential.
1/3 rd benign, 1/3rd locally aggressive, 1/3rd malignant.
Peak incidence between 20-40 yrs of age.
Female>Male.
Located at epiphysis. Tumor originated at epiphyseis & may extend into
metaphysis.
Bones affected: lower end of femur, upper end of tibia, lower end of radius.
Pathogenesis: Neoplastic cells are primitive osteoblast precursors expressing
high level of RANKL-> promotes proliferation of osteoclastic precursors->
differentiate into mature osteoclasts.
Absence of feedback between osteoblasts & osteoclasts-> localized but highly
destructive bone resorption.
Acquired mutation in gene encoding histone 3.3-> mechanism unknown.
Presenting features:
Swelling & vague pain, pathological #.
On examination: bony swelling, eccentrically located at the end of bone.
Surface of swelling – smooth.
Tenderness on deep palpation.
Deformity of limb if pathological # occurs.
Radiological features:
Radiolucent, expansile, eccentric solitary lytic lesion.
Soap-bubble appearance: tumor is homogenously lytic with trabeculae of remnants
of bone traversing it, giving rise to a loculated appearance.
No calcification within tumor.
No periosteal reaction.
Thinned out cortex.
Expansile lytic lesion with thinned out cortex and soap-bubble appearance
at distal end of radius: GCT
Gross morphology: GCT
cut surface is solid or friable
variegatedred–brown and yellow appearance.
Hemorrhage, necrosis and cystic change may be prominent.
When the cortex is thinned or destroyed, a thin rim of reactive bone may surround
the tumor.
Microscopic features:
Two main components:
1. sheets of round, oval or elongated mononuclear stromal cells with an open
chromatin pattern (there are actual neoplastic cells).
2. Osteoclast-like large multinucleate giant cells with nuclei (more than 20-30
nuclei) similar to those of the mononuclear stromal neoplastic cells. There are
evenly interposed with stromal mononuclear neoplastic cells.
Variable number of mitotic figures.
Secondary changes: haemorrhage, necrosis, cystic change, fibrohistiocytic
change.
Prognosis:
Treated by curettage.
40-60% recur locally.
4% metastasize to lung: may regress spontaneously, seldom fatal.
RANKL inhibitor Denosumab is recent promising adjuvant therapy.
Malignant GCT:
Sarcomatous lesion arising within a GCT, or as a sarcoma that appears in the
same area in which a bona fide GCT was treated.
Giant cell containing lesions of bone:
1. Giant cell tumor of bone
2. Fibrous cortical defect/ Non-ossifying fibroma
3. Chondromyxoid fibroma
4. Chondroblastoma
5. Langerhans cell histiocytosis
6. Brown tumor of hyperparathyroidism
7. Giant cell reparative granuloma
8. Aneurysmal bone cyst
“One of the main microscopic differences between true giant cell tumor and these
mimics resides in the spatial relationship between the giant and stromal cells.
Giant cells tend to be distributed regularly and uniformly in giant cell tumor
whereas in the lesions that simulate it, foci containing numerous, clumped giant
cells alternate with large areas completely lacking this component.”
Ewings sarcoma:
2nd most common bone sarcoma in children.
Age: 5 – 20 yrs of age
occurs most often in long bones (femur, tibia, humerus, and fibula) and in bones of
the pelvis, ribs, vertebrae, and clavicle.
Location: diaphysis of long tubular bones.
Pathogenesis: Balanced translocation t(11;22)-> creating EWSR1/FLI1 fusion
gene-> encodes EWS/FLI1 protein->binds to chromatin-> dysregulates
transcription-> uncontrolled growth & abnormal differentiation.
Cell of origin: mesenchymal stem cells & primitive neuroectodermal cells.
Clinical features:
Presents with a painful enlarging mass.
On examination: affected site – tender, warm, swollen.
Systemic features – fever, leucocytosis, elevated ESR [mimics Pyogenic
osteomyelitis].
Radiological findings:
destructive lytic tumor.
permeative, or moth-eaten margins extending into surrounding soft tissues.
The characteristic periosteal reaction produces layers of reactive bone deposited in an
onion-skin fashion.
Gross morphology:
Involves large area, or even entire medullary cavity.
Cut section – gray white, soft, thin; sometimes like pus.
Bone is expanded.
Periosteum elevated with subperiosteal new bone formation
Tumor ruptures through cortex-> extends into adjacent soft tissue.
Microscopic features:
Solid sheets of cells divided into irregular nests by fibrovascular septa.
Individual cells are primitive, small, and uniform.
The cell outlines are indistinct, resulting in a “syncytial” appearance.
The nuclei are round, with frequent indentations, small nucleoli,
variable mitotic activity.
There is a well-developed vascular network. Some of the tumor cells may arrange
themselves around the vessels in a pseudorosette fashion.
Necrosis is common.
IHC: tumor cells are positive for CD99.
Molecular genetics: detection of reciprocal translocation of t(11;22)(q24;q12) or
t(21;22)(q22;q12).
Spread & metastasis:
The metastatic spread of ES/PNET is to the lungs and pleura, other bones
(particularly the skull), central nervous system, and (rarely) regional lymph nodes.
About 25% of patients have multiple bone and/or visceral lesions at the time of
presentation.
Prognosis:
Neoadjuvant chemotherapy+surgery+Post op adjuvant chemotherapy with or
without radiation -> 5 year survival is of 75%.
Chemotherapy induced necrosis – positive prognostic indicator.